Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-13 Sale |
2025-03-13 4:13 pm |
Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer |
143 | $12.12 | $1,733 | 96,057 (Direct) |
View |
| 2025-03-11 Sale |
2025-03-13 4:08 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
1,343 | $11.38 | $15,283 | 122,330 (Direct) |
View |
| 2025-03-11 Sale |
2025-03-13 4:08 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,153 | $11.38 | $24,501 | 195,840 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 4:08 pm |
Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer |
1,343 | $11.83 | $15,888 | 94,157 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 4:07 pm |
Dyne Therapeutics Inc. | DYN | Cox John CEO & President |
4,061 | $11.83 | $48,042 | 178,239 (Indirect Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 4:06 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
917 | $11.83 | $10,848 | 123,673 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 4:04 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
1,094 | $11.83 | $12,942 | 197,993 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-25 5:09 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,598 | $13.95 | $36,242 | 199,087 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-18 5:09 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,488 | $13.95 | $34,708 | 124,590 (Direct) |
View |
| 2024-12-11 Sale |
2024-12-11 8:41 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,334 | $28.12 | $65,632 | 201,685 (Direct) |
View |
| 2024-12-11 Sale |
2024-12-11 8:40 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
1,455 | $28.12 | $40,915 | 127,078 (Direct) |
View |
| 2024-12-06 Sale |
2024-12-10 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
136,112 | $29.3 | $3,988,016 | 5,462,846 (Indirect) |
View |
| 2024-12-04 Sale |
2024-12-06 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
138,845 | $29.38 | $4,079,361 | 5,598,958 (Indirect) |
View |
| 2024-12-02 Sale |
2024-12-04 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
110,933 | $29.5 | $3,273,008 | 5,737,803 (Indirect) |
View |
| 2024-11-18 Sale |
2024-11-18 7:42 pm |
Dyne Therapeutics Inc. | DYN | Incerti Carlo Director |
16,500 | $28.73 | $474,045 | 22,693 (Direct) |
View |
| 2024-11-14 Sale |
2024-11-18 5:31 pm |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
782 | $33.1 | $25,884 | 847,316 (Indirect) |
View |
| 2024-11-18 Sale |
2024-11-18 4:28 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,735 | $28.2 | $77,127 | 95,833 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-18 4:28 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,856 | $28.2 | $80,539 | 137,519 (Direct) |
View |
| 2024-11-13 Sale |
2024-11-15 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
19,732 | $34.14 | $673,748 | 5,786,435 (Indirect) |
View |
| 2024-10-18 Sale |
2024-10-22 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
13,535 | $35.16 | $475,878 | 5,868,468 (Indirect) |
View |
| 2024-10-16 Sale |
2024-10-18 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
36,684 | $35.29 | $1,294,437 | 5,882,003 (Indirect) |
View |
| 2024-10-03 Sale |
2024-10-07 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
5,441 | $35.13 | $191,142 | 5,918,687 (Indirect) |
View |
| 2024-10-01 Sale |
2024-10-03 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
29,941 | $35.32 | $1,057,460 | 5,924,128 (Indirect) |
View |
| 2024-09-27 Sale |
2024-10-01 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
30,974 | $35.5 | $1,099,697 | 5,954,069 (Indirect) |
View |
| 2024-09-25 Sale |
2024-09-27 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
3,617 | $35.14 | $127,102 | 5,985,043 (Indirect) |
View |
| 2024-09-20 Sale |
2024-09-24 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
120,242 | $36.07 | $4,336,893 | 5,988,660 (Indirect) |
View |
| 2024-09-18 Sale |
2024-09-20 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
80,293 | $36.15 | $2,902,720 | 6,108,902 (Indirect) |
View |
| 2024-09-18 Sale |
2024-09-19 4:52 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
8,976 | $34.41 | $308,864 | 131,636 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-19 4:52 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
1,390 | $34.55 | $48,024 | 98,568 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-19 4:51 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,339 | $34.55 | $80,812 | 140,375 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-18 4:05 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
4,592 | $35.1 | $161,198 | 6,189,195 (Indirect) |
View |
| 2024-09-11 Sale |
2024-09-11 4:13 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,161 | $31.89 | $68,914 | 142,714 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-01 4:33 pm |
N/A 2035-03-30 |
Dyne Therapeutics Inc. | DYN | Lucera Erick Chief Financial Officer |
280,600 | $0 | 280,600 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 4:15 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
1,111,111 | $13.5 | 9,130,465 (Indirect) |
View |
| 2024-12-04 Option Award |
2024-12-06 4:05 pm |
N/A 2034-12-03 |
Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer |
98,100 | $0 | 156,500 (Direct) |
View |
| 2024-12-04 Option Award |
2024-12-06 4:05 pm |
N/A 2034-12-03 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
85,000 | $0 | 180,833 (Direct) |
View |
| 2024-12-04 Option Award |
2024-12-06 4:05 pm |
N/A 2034-12-03 |
Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer |
124,600 | $0 | 172,100 (Direct) |
View |
| 2024-12-04 Option Award |
2024-12-06 4:05 pm |
N/A 2034-12-03 |
Dyne Therapeutics Inc. | DYN | Cox John CEO & President |
377,400 | $0 | 414,400 (Direct) |
View |
| 2024-12-04 Option Award |
2024-12-06 4:05 pm |
N/A 2034-12-03 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
128,900 | $0 | 266,419 (Direct) |
View |
| 2024-11-18 Exercise |
2024-11-18 7:42 pm |
N/A 2032-03-01 |
Dyne Therapeutics Inc. | DYN | Incerti Carlo Director |
16,500 | $0 | 22,693 (Direct) |
View |
| 2024-11-18 Exercise |
2024-11-18 7:42 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Incerti Carlo Director |
16,500 | $8.69 | 22,693 (Direct) |
View |